Skin Testing and ELISPOT Assay in Patients With a History of Non-Immediate Reactions to Cephalosporins
NCT01248377 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28
Last updated 2011-10-12
Summary
This study aims to compare the results of skin testing and ELISPOT assay in patients with a history of non-immediate reactions to cephalosporins
Conditions
- Cephalosporin Allergy
- Non-immediate Drug Reactions
Interventions
- PROCEDURE
-
Skin tests and ELISPOT assay
Patch test and/or intradermal test will be performed in patients as well as cytokine secretions from PBMCs will be analyzed by ELISPOT assay
Sponsors & Collaborators
-
Chulalongkorn University
lead OTHER
Principal Investigators
-
Jettanong Klaewsongkram, MD · Chulalongkorn University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-06-30
- Primary Completion
- 2011-05-31
- Completion
- 2011-05-31
Countries
- Thailand
Study Locations
More Related Trials
-
Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia
NCT01701219 ·Status: COMPLETED ·Phase: PHASE4
-
Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections
NCT03802552 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections
NCT00352612 ·Status: COMPLETED ·Phase: PHASE4
-
Colistin Monotherapy vs Colsitin-fosfomycine in CRAB Infection
NCT06570850 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006)
NCT01922011 ·Status: COMPLETED ·Phase: PHASE3
-
Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline
NCT01724671 ·Status: UNKNOWN
-
Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA
NCT02582203 ·Status: COMPLETED ·Phase: PHASE4
-
A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects
NCT02439359 ·Status: COMPLETED ·Phase: PHASE1
-
Cellulitis Optimal Antibiotic Treatment
NCT05584007 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection
NCT06051513 ·Status: RECRUITING ·Phase: NA
-
Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection
NCT03747497 ·Status: COMPLETED ·Phase: PHASE2
-
RCT Cefiderocol vs BAT for Treatment of Gram Negative BSI
NCT03869437 ·Status: COMPLETED ·Phase: PHASE2
-
High-dose vs. Standard-dose Cephalexin for Cellulitis
NCT04471246 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Label Study to Describe the Pharmacokinetics of Cefazolin in Preterm Neonates
NCT00850122 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections
NCT01400867 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
NCT01499277 ·Status: COMPLETED ·Phase: PHASE3
-
Cefotetan Therapy for Escherichia Coli Infections
NCT07318584 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Pharmacological Study of High Doses of Ceftriaxone in Meningitidis
NCT01745679 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia
NCT00621504 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Teledermatology on Length of Hospital Admission, Length of Stay, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic ED Setting
NCT03036358 ·Status: COMPLETED ·Phase: NA
-
Effect of Administration of 3rd Generation Cephalosporin on the Digestive Carrying of 3rd Generation Cephalosporin-resistant Enterobacteriaceae (CEF-IMPACT)
NCT03922919 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Dermatology and Teledermatology Consultations on Length of Hospital Admission, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic Inpatient Setting
NCT03034694 ·Status: COMPLETED ·Phase: NA
-
Detection of Colistin-resistant Isolates From Patients of Intensive Care Units and Oncohaematology Wards.
NCT03971877 ·Status: COMPLETED
-
Efficacy of Colistin Monotherapy Versus Colistin Plus Minocycline for Carbapenem-Resistant A. Baumannii Infection
NCT05586815 ·Status: UNKNOWN ·Phase: PHASE4
-
Intra-nodal Injection of Gentamicin for the Treatment of Suppurated Cat Scratch Disease's Lymphadenitis
NCT03132116 ·Status: COMPLETED ·Phase: PHASE3